Remove Cannabinoids Remove Chronic Pain Remove Data Remove Therapy
article thumbnail

Sapphire Medical Clinics present new data from the UK Medical Cannabis Registry at the 31st Annual International Cannabinoid Research Society Symposium on Cannabinoids

Cannabis Law Report

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes.

article thumbnail

Patients Frequently Substituting Cannabis For Anti-Anxiety Drugs

NORML

According to data compiled by the US Centers for Disease Control, the drug was attributed to over 11,500 overdose deaths in 2017. They reported that 30 percent of participants discontinued their use of anti-anxiety medications within two-months of initiating cannabis therapy, and that 45 percent did so by six-months.

Patients 242
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why Terpenes Are Vital To Your Cannabinoid Therapy

StrainConnect

Why Terpenes Are Vital To Your Cannabinoid Therapy. 3,4] By observing the terpene profile, cannabinoid presence and potency, and quantity of standard biomolecules like lipids and waxes, scientists can identify different chemovars. Terpenes also interact with the cannabinoids to help the therapeutic benefits take effect!

article thumbnail

States That Restrict MMJ Access Are Interfering With Patients’ Rights, Study Shows

Veriheal

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. How Do MMJ Restrictions Affect Patients and Doctors?

Access 98
article thumbnail

Medical cannabis studies offer hope to opioid users

Healer

For years, Tim Gresh took dozens of prescription opioid medications per day, seeking any relief for the debilitating back pain that he – no matter which medication or therapy he used – could just not shake. . “It THC is the main psychoactive compound in marijuana, while CBD is a non-intoxicating cannabinoid found in the cannabis plant.

article thumbnail

MyMD Pharmaceuticals Announces New Data Demonstrating 8,000 Times Higher Potency of Novel Synthetic Supera-CBD over Plant-Derived CBD

Cannabis Law Report

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

article thumbnail

Why is US Cannabis Research Funded to Focus on Adverse Effects?

Veriheal

Of that, the American National Institute on Drug Abuse (NIDA) has invested just over $1 billion and has allocated far more money to researching cannabis misuse and the negative effects of consuming cannabis and its compounds as a form of therapy. The data for this graphic was provided by Jim Hudson at Hellth.com. . Canada, and the U.K)